The researchers discovered that upregulation of miR-141 led to a downregulation of HOXC6 and subsequent inhibition of the TGF-β signaling pathway, which effectively repressed EMT and reduced the viability, migration, and invasion abilities of laryngeal cancer cells, as well as tumor growth in vivo. Here, HOXC6 is linked to laryngeal carcinoma.